Merit Medical Systems, Inc.
Financials
Valuation Metrics
Merit Medical Systems, Inc.'s Market Cap is $5.03B. At end of 2025 it was $5.23B. Ranked #1316 of 3,118 in US market (top 42%), #438 of 1,474 on NASDAQ (top 30%), #89 of 203 in Health Care Equipment & Services (top 44%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.03B | US#1,316/3,118 Sec#89/203 |
| Revenue | $1.61B | US#1,572/3,118 Sec#96/203 |
| Net Income | $160M | US#1,451/3,118 Sec#74/203 |
| Total Assets | $2.92B | US#1,843/3,118 Sec#89/203 |
| Net Assets | $1.74B | US#1,369/3,118 Sec#71/203 |
| Employees | 7,500 | US#1,005/3,118 Sec#77/203 |
| Value | ||
| P/E | 31.42x | US#1,717/3,118 Sec#72/203 |
| P/B | 2.88x | US#1,806/3,118 Sec#95/203 |
| PEG | 0.89x | US#972/3,118 Sec#47/203 |
| P/S | 3.12x | US#1,830/3,118 Sec#123/203 |
| EV/EBITDA | 14.17x | US#1,536/3,118 Sec#59/203 |
| FCF Yield | 4.06% | US#1,608/3,118 Sec#85/203 |
| Profitability | ||
| ROE | 9.18% | US#1,517/3,118 Sec#74/203 |
| ROA | 5.47% | US#1,025/3,118 Sec#64/203 |
| Op. Margin | 13.49% | US#1,356/3,118 Sec#56/203 |
| Revenue Growth | 9.18% | US#1,218/3,118 Sec#83/203 |
| Earnings Growth | 35.20% | US#809/3,118 Sec#43/203 |
| Financial Health | ||
| Debt Ratio | 67.66% | US#777/3,118 Sec#81/203 |
| Total Debt | $822M | US#1,627/3,118 Sec#87/203 |
| FCF | $204M | US#1,369/3,118 Sec#83/203 |
| Cash | $504M | US#1,137/3,118 Sec#67/203 |
| Current Ratio | 4.52x | US#545/3,118 Sec#52/203 |
| Net Debt/EBITDA | 0.84x | US#978/3,118 Sec#56/203 |
| Performance | ||
| 1Y Return | -3.66% | US#1,698/3,118 Sec#126/203 |
| 1M Return | -1.21% | US#1,778/3,118 Sec#136/203 |
| From 52W High | -11.08% | US#724/3,118 Sec#68/203 |
| 1Y MDD | -35.28% | US#1,660/3,118 Sec#99/203 |
| Trading | ||
| Volume | 999,978 shares | US#1,110/3,118 Sec#60/203 |
| Trading Value | $85M | US#707/3,118 Sec#58/203 |
| Per Share | ||
| EPS | $2.68 | US#1,203/3,118 Sec#63/203 |
| BPS | $29.24 | US#938/3,118 Sec#56/203 |
Company Info
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.